Purpose
To ensure the financing of the Group’s growth investments, the 16th resolution invites you to renew the delegation allowing the Board of Directors to increase the share capital by a maximum nominal amount of 470 million euros, corresponding to approximately 15% of the share capital as of December 31, 2024, by issuing, on one or more occasions, ordinary shares or dilutive compound marketable securities. Shareholders shall have, in proportion to the number of shares they hold, a preferential subscription right to the shares or the marketable securities thus issued.
The Board of Directors did not make use of the previous authorization granted by the Extraordinary General Meeting of May 3, 2023. This delegation is valid for a period of 26 months.
The total amount of the share capital increases that may be carried out under the 17th resolution below and the resolutions allowing employees and Company Officers to benefit from shares (18th and 19th resolutions of this General Meeting), subject to their approval, and resolutions allowing the implementation of employee shareholding transactions (20th and 21st resolutions submitted to this General Meeting), subject to their approval will also be deducted from this limit of 470 million euros.
As in 2023, in order to provide Shareholders with the right to express an opinion on the issues that are the subject of this delegation during periods of takeover bids, it is proposed that this delegation of authority be suspended during periods of takeover bids.
In the event of oversubscription, the 17th resolution allows the amount of the issue initially provided for to be increased to a maximum of 15% (legal limit), subject to a maximum of 470 million euros.
(Delegation of authority granted to the Board of Directors for a period of 26 months to increase the share capital via the issuance of ordinary shares or marketable securities giving access, immediately and/or in the future, to the Company’s share capital with retention of preferential subscription rights for Shareholders for a maximum nominal amount of 470 million euros)
The General Meeting, deliberating according to the quorum and majority required for Extraordinary General Meetings, after having noted the Board of Directors’ Report and the Statutory Auditors’ Special Report, pursuant to articles L. 225-129 to L. 225-129-6, L. 22-10-49 and L. 228-91 to L. 228-93 of the French Commercial Code:
delegates to the Board of Directors, with the possibility of sub-delegation under the conditions set by law, the authority to decide, on one or more occasions, in the proportions and at the times it deems fit, with retention of preferential subscription rights, the issue, in France and abroad, in euros, in foreign currencies or in units of account set by reference to several currencies, (i) of ordinary shares of the Company, (ii) of marketable securities governed by articles L. 228-91 et seq. of the French Commercial Code which are equity securities of the Company, giving access to other equity securities of the Company and/ or giving entitlement to the allocation of debt securities of the Company and/or (iii) marketable securities representing a claim, whether or not governed by articles L. 228-91 et seq. of the French Commercial Code, giving access to or likely to give access to equity securities of the Company to be issued, with the possibility that these marketable securities may, where applicable, also give access to existing equity securities and/ or debt securities of the Company, the subscription of which may be made either in cash or by offsetting against liquid and payable receivables.
The delegation thereby granted to the Board of Directors is valid for a period of 26 months starting from the date of this General Meeting, it being specified, however, that the Board of Directors will not be authorized to make use of it during periods of takeover bids on the Company’s share capital;